IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) — Market Cap & Net Worth
Market Cap & Net Worth: IOL Chemicals and Pharmaceuticals Limited (IOLCP)
IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) has a market capitalization of $400.16 Million (Rs37.00 Billion) as of June 17, 2026. Listed on the NSE stock exchange, this India-based company holds position #13575 globally and #670 in its home market, demonstrating a -0.68% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying IOL Chemicals and Pharmaceuticals Limited's stock price Rs126.06 by its total outstanding shares 293527510 (293.53 Million). Review IOLCP current and long-term liabilities to assess the company's total debt and financial obligations.
IOL Chemicals and Pharmaceuticals Limited Market Cap History: 2015 to 2026
IOL Chemicals and Pharmaceuticals Limited's market capitalization history from 2015 to 2026. Data shows growth from $219.43 Million to $400.16 Million (4.86% CAGR).
Index Memberships
IOL Chemicals and Pharmaceuticals Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$147.46 Billion | 0.27% | #127 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.01% | #502 of 750 |
Weight: IOL Chemicals and Pharmaceuticals Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
IOL Chemicals and Pharmaceuticals Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how IOL Chemicals and Pharmaceuticals Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
IOL Chemicals and Pharmaceuticals Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.29x
IOL Chemicals and Pharmaceuticals Limited's market cap is 0.29 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $233.78 Million | $7.02 Billion | $46.70 Million | 0.03x | 5.01x |
| 2018 | $497.45 Million | $9.62 Billion | $277.00 Million | 0.05x | 1.80x |
| 2019 | $520.47 Million | $16.85 Billion | $2.37 Billion | 0.03x | 0.22x |
| 2020 | $2.26 Billion | $18.94 Billion | $3.61 Billion | 0.12x | 0.63x |
| 2021 | $1.48 Billion | $19.46 Billion | $4.45 Billion | 0.08x | 0.33x |
| 2022 | $1.16 Billion | $21.84 Billion | $1.68 Billion | 0.05x | 0.69x |
| 2023 | $1.45 Billion | $22.02 Billion | $1.39 Billion | 0.07x | 1.04x |
| 2024 | $1.29 Billion | $21.19 Billion | $1.34 Billion | 0.06x | 0.96x |
| 2025 | $261.13 Million | $20.68 Billion | $1.01 Billion | 0.01x | 0.26x |
| 2026 | $400.16 Million | $23.19 Billion | $1.38 Billion | 0.02x | 0.29x |
Competitor Companies of IOLCP by Market Capitalization
Companies near IOL Chemicals and Pharmaceuticals Limited in the global market cap rankings as of June 17, 2026.
Key companies related to IOL Chemicals and Pharmaceuticals Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #561 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.22 |
| #624 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.20 Billion | CN¥47.35 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
IOL Chemicals and Pharmaceuticals Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, IOL Chemicals and Pharmaceuticals Limited's market cap moved from $219.43 Million to $ 400.16 Million, with a yearly change of 4.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs400.16 Million | +53.25% |
| 2025 | Rs261.13 Million | -79.82% |
| 2024 | Rs1.29 Billion | -10.95% |
| 2023 | Rs1.45 Billion | +25.71% |
| 2022 | Rs1.16 Billion | -21.95% |
| 2021 | Rs1.48 Billion | -34.51% |
| 2020 | Rs2.26 Billion | +334.42% |
| 2019 | Rs520.47 Million | +4.63% |
| 2018 | Rs497.45 Million | +112.79% |
| 2017 | Rs233.78 Million | -18.33% |
| 2016 | Rs286.24 Million | +30.45% |
| 2015 | Rs219.43 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of IOL Chemicals and Pharmaceuticals Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $400.16 Million USD |
| MoneyControl | $400.16 Million USD |
| MarketWatch | $400.16 Million USD |
| marketcap.company | $400.16 Million USD |
| Reuters | $400.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, pa… Read more